Single-Cell Rapid Identification, In Situ Viability and Vitality Profiling, and Genome-Based Source-Tracking for Probiotics Products

We are pleased to announce that Dr. Jian Xu from Qingdao Institute of BioEnergy and Bioprocess Technology, China will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “Single-Cell Rapid Identification, In Situ Viability and Vitality Profiling, and Genome-Based Source-Tracking for Probiotics Products“. Summary: Dr. Jian Xu, Founding Director…

Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy

We are pleased to announce that Dr. Sin-Hyeog Im from Pohang University of Science and Technology, Korea will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy“. Summary: Dr. Sin-Hyeog Im, a leading expert in immunology and microbiome research, will discuss how…

Trimethylamine N-Oxide (TMAO) Increases with Age in Circulation and Promotes Sarcopenia

We are pleased to announce that Dr. Ippei Shimizu from National Cerebral and Cardiovascular Center Research Institute, Japan will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “Trimethylamine N-Oxide (TMAO) Increases with Age in Circulation and Promotes Sarcopenia“. Summary: Dr. Ippei Shimizu, a leader in cardiovascular science, will…

Microbiota-Metabolite Control of Cardiac Injury and Repair

We are pleased to announce that Dr. Patrick C.H. Hsieh from Institute of Biomedical Sciences, Academia Sinica, Taiwan will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “Microbiota-Metabolite Control of Cardiac Injury and Repair“. Summary: Dr. Patrick C.H. Hsieh, a distinguished cardiovascular surgeon and physician-scientist specializing in regenerative…